Evidence map›Paper›PMID 39724095›Full record

Observational studyThe Journal of clinical psychiatry2024

Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS).

Christoffer Brynte, Arnt Schellekens, Csaba Barta, Alex H A Begeman, Cleo L Crunelle, Costanza Daigre, Zsolt Demetrovics, Geert Dom, Lara Grau-López, Mariely Hernandez and 16 more

Abstract readObservational StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The Journal of clinical psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Christoffer BrynteDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Arnt SchellekensDepartment of Psychiatry, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, Radboud University Medical Centre, The Netherlands.
Csaba BartaDepartment of Molecular Biology, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary.
Alex H A BegemanDe Hoop ggz, Outpatient Treatment Centre Amersfoort, Amersfoort, The Netherlands.
Cleo L CrunelleDepartment of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Costanza DaigreDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Zsolt DemetrovicsInstitute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.
Geert DomCollaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Wilrijk, Belgium.
Lara Grau-LópezDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Mariely HernandezNew York State Psychiatric Institute, Columbia University, New York, New York.
Romain IcickAssistance Publique - Hôpitaux de Paris, Hôpital Fernand-Widal, Département Universitaire de Psychiatrie et de Médecine Addictologique, Paris, France.
Brian JohnsonSUNY Upstate, Syracuse, New York, New York.
Máté Kapitány-FövényNyír}o Gyula National Institute of Psychiatry, and Addictology, Budapest, Hungary.
Michiel van KernebeekDepartment of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Maija KonsteniusDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Frances R LevinColumbia University Irving Medical Center/New York State Psychiatric Institute, New York, New York.
Mathias LudererDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, Hospital of the Goethe University, Goethe University Frankfurt, Frankfurt, Germany.
Frieda MatthysDepartment of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Franz MoggiUniversity Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
J Antoni Ramos-QuirogaDepartment of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Laura SchleussnerDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, Hospital of the Goethe University, Goethe University Frankfurt, Frankfurt, Germany.
Norman TherriboutUniversité de Paris Cité, INSERM UMR-S1144, Paris, France.
Anil ThomasNYU Grossman School of Medicine, New York, New York.
Florence VorspanAssistance Publique - Hôpitaux de Paris, Hôpital Fernand-Widal, Département Universitaire de Psychiatrie et de Médecine Addictologique, Paris, France.
Wim van den BrinkDepartment of Psychiatry, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Johan FranckDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Funding

Translational Clinical Research Fellowship on Substance Use DisordersT32DA007294 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Frances Rudnick Levin, Diana M Martinez · 1993 to 2026
$9.3M
NIDA NIH HHS T32 DA007294
6 · The paper itself

Abstract

Indexed as

Attention Deficit Disorder with HyperactivitySubstance-Related DisordersAdultComorbidityFemaleHumansMaleMiddle AgedProspective StudiesYoung Adult

Identifiers

PMID39724095
PMCPMC11992959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.